Chronic Renal Disease

Causes, Complications, and Treatment

  • Nancy Boucot Cummings
  • Saulo Klahr

Table of contents

  1. Front Matter
    Pages i-xvi
  2. Studies of Pathogenesis of Renal Disease

    1. Front Matter
      Pages 1-1
    2. Research Trends in Glomerular Diseases

    3. Cystic Diseases of the Kidney

      1. Kenneth D. Gardner Jr.
        Pages 41-46
      2. Jay Bernstein
        Pages 47-54
      3. Andrew P. Evan, Kenneth D. Gardner Jr.
        Pages 55-68
      4. William M. Bennett, Curtis G. Wickre, Richard S. Muther
        Pages 89-93
      5. Larry W. Welling, Dan J. Welling
        Pages 95-103
      6. Joseph H. Holmes, Patricia Gabow
        Pages 105-112
  3. Recent Advances on Some Complications of Chronic Renal Failure

    1. Front Matter
      Pages 113-113
    2. Renal Osteodystrophy, Vitamin D Analogues, Parathormone

      1. Saulo Klahr, Eduardo Slatopolsky, Kevin Martin
        Pages 117-125
      2. Steven L. Teitelbaum
        Pages 127-138
      3. Jacob Lemann Jr., Richard W. Gray, Nancy D. Adams
        Pages 139-153
      4. Eduardo Slatopolsky, Kevin Martin, Keith Hruska, Saulo Klahr
        Pages 155-163
      5. Stephen M. Krane
        Pages 165-172

About this book


Chronic renal disease has received increasing attention and concern since the passage in 1972 of PL 92-603, which provided coverage for end-stage renal disease (ESRD) treatment by the federal government. The human and economic costs of the ESRD program serve to emphasize the need to prevent or to arrest those diseases resulting in chronic renal failure, since none of the available treatments is without complications and/or side effects. The ESRD program, the only federal one that provides coverage for a catastrophic illness for almost the entire population (those qualifying under Social Security), cost almost $2 billion in 1983. The escalating costs of the ESRD program are attributed to the increasing number of patients requiring treatment and have focused concerns of the United States Government, both Congress and the administration, on ESRD. The National Institutes of Health (NIH), especially the Kidney, Urology, and Hematology Division of the National Institutes of Arthritis, Diabetes, and Digestive and Kidney Diseases (NIADDK), supports a sizable research program that bears on chronic renal disease and in association with this has sponsored many conferences and workshops on research on and causes and complications of chronic renal failure. This book is an outgrowth of the issues addressed by participants at a number of NIH conferences held in the 1980s.


diseases glomerulonephritis growth kidney nutrition pathology physiology therapy transplantation urology

Editors and affiliations

  • Nancy Boucot Cummings
    • 2
  • Saulo Klahr
    • 1
  1. 1.Washington University School of MedicineSt. LouisUSA
  2. 2.National Institutes of HealthBethesdaUSA

Bibliographic information

  • DOI
  • Copyright Information Springer-Verlag US 1985
  • Publisher Name Springer, Boston, MA
  • eBook Packages Springer Book Archive
  • Print ISBN 978-1-4684-4828-3
  • Online ISBN 978-1-4684-4826-9
  • About this book